Immune checkpoint inhibitors and potential risk of thromboembolic events: Analysis of the WHO global database of individual case safety reports

INTRODUCTION: Thromboembolic events with the use of immune checkpoint inhibitors (ICIs) in patients with cancer have been reported in few studies. However, the detailed profile of these cases remains mostly uncertain. METHOD: A descriptive analysis of Thromboembolic events associated with ICIs retri...

Descripción completa

Detalles Bibliográficos
Autores principales: Alghamdi, Eman A., Aljohani, Hadir, Alghamdi, Waad, Alharbi, Fawaz
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508630/
https://www.ncbi.nlm.nih.gov/pubmed/36164566
http://dx.doi.org/10.1016/j.jsps.2022.06.010

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9508630/
https://www.ncbi.nlm.nih.gov/pubmed/36164566
http://dx.doi.org/10.1016/j.jsps.2022.06.010

Ejemplares similares